A recent PhD recipient at the University of Texas at Dallas has been selected by the Howard Hughes Medical Institute for a ...

The University of Cincinnati’s Jun-Ming Zhang has received a five-year, $3.1 million grant from the National Institute of ...

Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...

No evidence of clinically significant immune responses in any patient who received the revised immunosuppression regimen. No evidence of dorsal root ganglion (DRG) toxicity, as measured by nerve ...

Capsida Biotherapeutics yesterday revealed US pharma major AbbVie has exercised an option for the first neurodegenerative ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

On 30 December 2024, Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached ...

Here is a list of our partners and here's how we make money. Safe drivers may save with Root, which sets its rates primarily based on driving history, but its discount offerings are limited.

Yorkshire batter Root, who has not played ODI cricket since the World Cup in November 2023, returns in an ODI-only capacity. England Test captain Stokes was not considered for selection as he ...